Síndrome de apnea-hipopnea del sueño: Concepto, diagnóstico y tratamiento médico

Eguía, V. M.; Rodrigo, José Antonio Cascante

doi:10.4321/s1137-66272007000200005

Cited by 11 publications

(10 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The device cannot distinguish obstructive apneas from central or mixed ones. However, the employed portable monitor complies with the Standards of the Practice Committee of the American Sleep Disorders Association that establishes that portable monitoring is an adequate method for clinical therapeutic decision making, with an agreement with polysomnography (PSG) of ∼90% [ 37 , 38 ].…”

Section: Discussionmentioning

confidence: 99%

“…Apnea is defined as the absence or reduction in the amplitude of the respiratory flow signal over 90%, measured using an oronasal thermal sensor, lasting more than 10 seconds. Furthermore, apnea is obstructive if accompanied by a respiratory effort measured in the thoracoabdominal bands; it is central in the absence of such respiratory effort and is mixed if it starts as central and ends with respiratory effort [ 18 ].…”

Section: Methodsmentioning

confidence: 99%

“…The ApneaLink device is a single-channel screening tool for sleep apnea consisting of a nasal cannula attached to a small case that houses a pressure transducer. The device is held in place by a belt worn around the user's chest [ 23 , 24 ]. The ApneaLink device operates on battery power and has a sampling rate of 100 Hz with a 16 bit signal processor.…”

Section: Methodsmentioning

confidence: 99%

See 2 more Smart Citations

Apnea-Hypopnea Index in Chronic Obstructive Pulmonary Disease Exacerbation Requiring Noninvasive Mechanical Ventilation with Average Volume-Assured Pressure Support

Claudett

Lopez

Briones-Claudett³

et al. 2021

Critical Care Research and Practice

View full text Add to dashboard Cite

Introduction. This study intends to determine the Apnea-Hypopnea Index in patients hospitalized with acute hypercapnic respiratory failure from chronic obstructive pulmonary disease exacerbation, who require noninvasive ventilation with average volume-assured pressure support (AVAPS), as well as describes the clinical characteristics of these patients. Materials and Methods. We designed a single-center prospective study. The coexistence of Apnea-Hypopnea Index and clinical, gasometric, spirometric, respiratory polygraphy, and ventilatory characteristics were determined. The clinical characteristics found were categorized and compared according to the Apnea-Hypopnea Index (AHI) < 5, AHI 5–15, and AHI >15. A p value <0.05 was considered statistically significant. Results. During the study period, a total of 100 patients were admitted to the ICU with a diagnosis of acute hypercapnic respiratory failure due to COPD exacerbation. 72 patients presented with acute respiratory failure and fulfilled criteria for ventilatory support. Within them, 24 received invasive mechanical ventilation and 48 NIV. After applying the inclusion criteria for this study, 30 patients were eligible. An AHI >5 was present in 24 of the 30 patients recruited (80%). Neck circumference (cm), Epworth scale, and Mallampati score evidenced significant differences when compared to the patient’s AHI <5, AHI 5–15, and AHI >15 ( p < 0.05 ). Furthermore, patients with an AHI >5 had longer hospital admissions, prolonged periods on mechanical ventilation, and a higher percentage of intubation rates. Conclusion. Apnea-Hypopnea Index and chronic obstructive pulmonary disease exacerbation are a frequent association found in patients with acute hypercapnic respiratory failure and COPD exacerbations that require NIV. This association could be a determining factor in the response to NIV, especially when AVAPS is used as a ventilatory strategy.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Methodsmentioning

confidence: 99%

Section: Methodsmentioning

confidence: 99%

See 1 more Smart Citation

Apnea-Hypopnea Index in Chronic Obstructive Pulmonary Disease Exacerbation Requiring Noninvasive Mechanical Ventilation with Average Volume-Assured Pressure Support

Claudett

Lopez

Briones-Claudett³

et al. 2021

Critical Care Research and Practice

View full text Add to dashboard Cite

show abstract

“…-Síndrome de apnea-hipoapnea obstructiva del sueño (SAHS). Caracterizado por ESD, trastornos cognitivos, respiratorios, cardiacos, metabólicos o inflamatorios secundarios a episodios repetitivos de obstrucción de la vía aérea superior en el sueño 27 . En el TLMS puede haber latencias de entrada en sueño inferiores a 5 minutos y 2 o más entradas a REM.…”

Section: Diagnóstico Diferencialunclassified

Narcolepsy: update on etiology, clinical features and treatment

2010

An Sist Sanit Navar

View full text Add to dashboard Cite

La narcolepsia es una enfermedad que consiste en una alteración en la generación y organización del sueño. Los principales síntomas son la excesiva somnolencia diurna y la cataplejía así como las alucinaciones hipnagógicas, parálisis del sueño y fragmentación del sueño nocturno. La prevalencia de la narcolepsia típica oscila entre el 25 y 50 por cada 100.000 habitantes. Recientemente se ha observado un pico de incidencia en pacientes nacidos en el mes de marzo.

show abstract

“…Si se presentan más de 10 apneas o hipopneas por hora de sueño se considera anormal, si es mayor a 30 es grave. (3) La A.O.S es un trastorno frecuente, pero frecuentemente subdiagnosticada (4) . Las personas que presentan A.O.S.…”

Section: Introductionunclassified

Uso de Psicofármacos y Riesgo de Apnea del Sueño en pacientes internados en Hospital General

López-Rega

et al. 2022

Rev. chil. neuro-psiquiatr.

View full text Add to dashboard Cite

A cross-sectional study was conducted with the objective of identifying the link between psychotropic medications and an increased risk of suffering from obstructive sleep apnea (OSA) in patients under treatment with psychotropic medication who were hospitalized in General Hospital (Hospital Pasteur, Montevideo, Uruguay) during the July-September 2019 period. The STOP BANG questionnaire was applied, elevated risk of OSA was found in 59.4% of the sample, of which 75.6% were male, while 24.4% were female. The elevated risk of OSA was: 54.4% for patients under treatment with a single psychotropic medication and 71.4% for patients under treatment with two psychotropic medications. Antipsychotics were the most frequently group of psychotropic drugs linked to an elevated OSA risk.

show abstract

Síndrome de apnea-hipopnea del sueño: Concepto, diagnóstico y tratamiento médico

Cited by 11 publications

References 29 publications

Apnea-Hypopnea Index in Chronic Obstructive Pulmonary Disease Exacerbation Requiring Noninvasive Mechanical Ventilation with Average Volume-Assured Pressure Support

Apnea-Hypopnea Index in Chronic Obstructive Pulmonary Disease Exacerbation Requiring Noninvasive Mechanical Ventilation with Average Volume-Assured Pressure Support

Narcolepsy: update on etiology, clinical features and treatment

Uso de Psicofármacos y Riesgo de Apnea del Sueño en pacientes internados en Hospital General

Contact Info

Product

Resources

About